Replies to post #11908 on GeneSYS ID Inc fka GNID

[DCorleone]

Shouldn't we wait for the 8-k
RX SAFES INC.
NOTES TO THE FINANCIAL STATEMENTS
SEPTEMBER 30, 2015
(UNAUDITED)

On November 11, 2015 the Company entered into a binding letter of intent to purchase all right, title and interest to patent number 7,806,852. The Company will pay to the seller $100,000 in the form of warrants to purchase shares of the Companies common stock. The Company shall pay the seller $1.5 per unit on sales of current product as well as $3.00 per unit on sales of new devices incorporating the patented encasement. If the Company sells a majority interest or there is a change in management from the original founders, the seller has the option to continue the royalty agreement or take a one time $250,000 cash payout and waive future rights.